Sermo

Leading physician social network and healthcare insights platform for pharmaceutical market research

Sermo operates as the world's largest social network exclusively for verified physicians, connecting over 1.3 million doctors across 150 countries. The platform enables healthcare professionals to discuss clinical cases, share medical knowledge, and provide insights on treatments and therapies in a secure, anonymous environment. Beyond its community function, Sermo serves as a critical healthcare intelligence platform for pharmaceutical companies, medical device manufacturers, and healthcare market research firms seeking real-world physician perspectives on drugs, treatments, and healthcare trends. The company generates revenue primarily through its healthcare insights business, where pharmaceutical and life sciences companies pay to access physician opinions, conduct surveys, and gather real-world evidence. Sermo's unique value lies in its ability to provide rapid, authentic feedback from practicing physicians who are incentivized to participate through honoraria and professional development opportunities. The platform has become an essential tool for pharmaceutical marketing, medical affairs teams, and market research organizations seeking to understand physician prescribing behaviors, treatment patterns, and drug perceptions. Sermo was acquired by Citeline (a portfolio company of private equity firm Inflexion) in 2022, and continues to operate as a distinct brand within Citeline's healthcare intelligence portfolio. The acquisition strengthened Sermo's position in the pharmaceutical market research and healthcare data space, combining its physician network with Citeline's broader suite of drug development and commercial intelligence solutions.